SCHEMBL21136797

SCHEMBL21136797

CN(CCN1CCN(C)c2cnc3cc(Br)c(Cl)cc3c21)C(=O)OC(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
KRAS P01116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136786 0.92 CCNE2 (0.32) CCNE2CCNE1CDK2
SCHEMBL21136881 0.85 CCNE2 (0.33) CCNE2CCNE1CDK2
SCHEMBL21136745 0.84 ACKR3 (0.31) CCNE2CCNE1CDK2
SCHEMBL21137483 0.74 KRAS (0.49) KRAS
SCHEMBL21099209 0.74 KRAS (0.40) KRAS
SCHEMBL21099612 0.71 KRAS (0.50) KRAS
SCHEMBL21050747 0.67 KRAS (0.43) KRAS
SCHEMBL32677269 0.67 PLA2G10 (0.32) CCNE2CCNE1CDK2
SCHEMBL21136722 0.66 MAP4K4 (0.42)
SCHEMBL29998951 0.66 PIK3CD (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed